MYGN 15.49 (+2.45%)
US62855J1043• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MYGN

Myriad Genetics (MYGN) Competitor Comparison

We are evaluating the key criteria listed to compare Myriad Genetics (MYGN) against its competitors in the Diagnostics & Research industry.

Market Capitalization

28 / 58

Gross Profits

22 / 52

Total Revenue

25 / 57

EBITDA

51 / 56

Free Cashflow

42 / 56

Quick Ratio

44 / 57

Earnings per Share

43 / 56

Dividend yield

0 / 9

Total Cash

36 / 57

Performance 3 years

27 / 58

Performance 5 years

33 / 58

Performance 10 years

37 / 58

Linearity 3 years

22 / 58

Linearity 5 years

21 / 58

Linearity 10 years

13 / 58

Total Rank

23 / 58

Dividend Rank

22 / 58

Valuation Rank

28 / 58

Piotroski Rank

50 / 58

Muliplier Rank

56 / 58

Performance 5 years - MYGN ranking 33 / 58

These are the competitors of Myriad Genetics in the industry Diagnostics & Research ranked by performance 5 years
1. RadNet RDNT
414.34
2. Medpace Holdings MEDP
326.92
3. Lantheus Holdings LNTH
288.84
4. Natera NTRA
277.61
5. Meridian Bioscience VIVO
118.46
6. Danaher DHR
86.7
7. Twist Bioscience TWST
80.12
8. Thermo Fisher Scientific TMO
69.37
9. Waters WAT
67.76
10. Agilent Technologies A
65.18
11. Mettler-Toledo MTD
65.12
12. IDEXX Laboratories IDXX
63.14
13. DarioHealth DRIO
61.4
14. Laboratory Corp of America Holdings LH
61.22
15. Fulgent Genetics FLGT
58.84
16. Quest Diagnostics DGX
55.71
17. DexCom DXCM
49.22
18. PerkinElmer PKI
48.44
19. Charles River Laboratories CRL
36.04
20. IQVIA Holdings IQV
32.4
21. Co-Diagnostics CODX
26.44
22. Icon ICLR
23.92
23. Qiagen QGEN
14.87
24. Ortho Clinical Diagnostics Holdings OCDX
13.74
25. Heska HSKA
12.14
26. CareDx CDNA
9.22
27. Syneos Health SYNH
-16.98
28. Anixa Biosciences ANIX
-19.74
29. Bioventus BVS
-26.29
30. Olink Holding OLK
-26.82
31. NeoGenomics NEO
-32.52
32. Exact Sciences EXAS
-34.91
33. Myriad Genetics MYGN
-34.96
34. Sotera Health SHC
-44.48
35. Inotiv NOTV
-48.49
36. Illumina ILMN
-53.88
37. Neogen NEOG
-54.48
38. Sera Prognostics SERA
-57.1
39. Personalis PSNL
-57.47
40. Interpace Biosciences IDXG
-58.8
41. Enzo Biochem ENZ
-59.72
42. Guardant Health GH
-60.02
43. Pacific Biosciences of California PACB
-61.33
44. National Research NRC
-69.16
45. Trinity Biotech TRIB
-70.4
46. Psychemedics PMD
-75.03
47. MaxCyte MXCT
-79.75
48. bioAffinity Technologies BIAF
-84.17
49. Exagen XGN
-84.78
50. Precipio PRPO
-85.3
51. MDxHealth MDXH
-85.6
52. Global Cord Blood CO
-86.47
53. Biodesix BDSX
-89.7
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.98
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.